MFDS — authorised 5 March 1991
- Marketing authorisation holder: BERLEX LABS
- Status: likely_approved
🇰🇷 Leukine in South Korea
MFDS authorised Leukine on 5 March 1991
Marketing authorisation
Leukine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Leukine approved in South Korea?
Yes. MFDS authorised it on 5 March 1991.
Who is the marketing authorisation holder for Leukine in South Korea?
BERLEX LABS holds the South Korean marketing authorisation.